FDA Inspection 1250746 — Rubicon Research Limited
The FDA completed an inspection of Rubicon Research Limited on Nov 7, 2024 in Thane. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2024
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Thane (India)